249 related articles for article (PubMed ID: 22018955)
21. Rapid determination of serological cytokine biomarkers for hepatitis B virus-related hepatocellular carcinoma using antibody microarrays.
Liu T; Xue R; Dong L; Wu H; Zhang D; Shen X
Acta Biochim Biophys Sin (Shanghai); 2011 Jan; 43(1):45-51. PubMed ID: 21138899
[TBL] [Abstract][Full Text] [Related]
22. Serum human telomerase reverse transcriptase messenger RNA as a novel tumor marker for hepatocellular carcinoma.
Miura N; Maeda Y; Kanbe T; Yazama H; Takeda Y; Sato R; Tsukamoto T; Sato E; Marumoto A; Harada T; Sano A; Kishimoto Y; Hirooka Y; Murawaki Y; Hasegawa J; Shiota G
Clin Cancer Res; 2005 May; 11(9):3205-9. PubMed ID: 15867214
[TBL] [Abstract][Full Text] [Related]
23. Discovery of lamin B1 and vimentin as circulating biomarkers for early hepatocellular carcinoma.
Wong KF; Luk JM
Methods Mol Biol; 2012; 909():295-310. PubMed ID: 22903723
[TBL] [Abstract][Full Text] [Related]
24. [Screening hepatocellular carcinoma autoantibodies by serological proteome analysis].
Feng JT; Liu YK; Dai Z; Zhou HJ; Song HY; Qin LX; Jin H; Lu HJ; Tang ZY
Zhonghua Gan Zang Bing Za Zhi; 2005 Nov; 13(11):832-5. PubMed ID: 16313728
[TBL] [Abstract][Full Text] [Related]
25. Autoantibodies to survivin in patients with chronic hepatitis and hepatocellular carcinoma.
Yagihashi A; Asanuma K; Kobayashi D; Tsuji N; Torigoe T; Sato N; Watanabe N
Autoimmunity; 2005 Sep; 38(6):445-8. PubMed ID: 16278150
[TBL] [Abstract][Full Text] [Related]
26. A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis.
Llovet JM; Chen Y; Wurmbach E; Roayaie S; Fiel MI; Schwartz M; Thung SN; Khitrov G; Zhang W; Villanueva A; Battiston C; Mazzaferro V; Bruix J; Waxman S; Friedman SL
Gastroenterology; 2006 Dec; 131(6):1758-67. PubMed ID: 17087938
[TBL] [Abstract][Full Text] [Related]
27. Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinoma.
Wu C; Wang Z; Liu L; Zhao P; Wang W; Yao D; Shi B; Lu J; Liao P; Yang Y; Zhu L
J Gastroenterol Hepatol; 2009 Jan; 24(1):55-62. PubMed ID: 18823443
[TBL] [Abstract][Full Text] [Related]
28. Study of serum haptoglobin and its glycoforms in the diagnosis of hepatocellular carcinoma: a glycoproteomic approach.
Ang IL; Poon TC; Lai PB; Chan AT; Ngai SM; Hui AY; Johnson PJ; Sung JJ
J Proteome Res; 2006 Oct; 5(10):2691-700. PubMed ID: 17022640
[TBL] [Abstract][Full Text] [Related]
29. Cloning and expression of a developmentally regulated transcript MXR7 in hepatocellular carcinoma: biological significance and temporospatial distribution.
Hsu HC; Cheng W; Lai PL
Cancer Res; 1997 Nov; 57(22):5179-84. PubMed ID: 9371521
[TBL] [Abstract][Full Text] [Related]
30. Gene expression profiling of human HBV- and/or HCV-associated hepatocellular carcinoma cells using expressed sequence tags.
Yoon SY; Kim JM; Oh JH; Jeon YJ; Lee DS; Kim JH; Choi JY; Ahn BM; Kim S; Yoo HS; Kim YS; Kim NS
Int J Oncol; 2006 Aug; 29(2):315-27. PubMed ID: 16820872
[TBL] [Abstract][Full Text] [Related]
31. Toward the proteomic identification of biomarkers for the prediction of HBV related hepatocellular carcinoma.
He QY; Zhu R; Lei T; Ng MY; Luk JM; Sham P; Lau GK; Chiu JF
J Cell Biochem; 2008 Feb; 103(3):740-52. PubMed ID: 17557278
[TBL] [Abstract][Full Text] [Related]
32. Proteomics of hepatocellular carcinoma: serum vimentin as a surrogate marker for small tumors (Sun S; Poon RT; Lee NP; Yeung C; Chan KL; Ng IO; Day PJ; Luk JM
J Proteome Res; 2010 Apr; 9(4):1923-30. PubMed ID: 20121168
[TBL] [Abstract][Full Text] [Related]
33. Analyses of autoantibodies against tumor-associated antigens in patients with hepatocellular carcinoma.
Himoto T; Kuriyama S; Zhang JY; Chan EK; Kimura Y; Masaki T; Uchida N; Nishioka M; Tan EM
Int J Oncol; 2005 Oct; 27(4):1079-85. PubMed ID: 16142326
[TBL] [Abstract][Full Text] [Related]
34. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis.
Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Qiyong L; Fujii T; Sugimoto H; Takeda S; Nakao A
Ann Surg Oncol; 2010 Mar; 17(3):923-32. PubMed ID: 19898900
[TBL] [Abstract][Full Text] [Related]
35. Preneoplastic markers of hepatitis B virus-associated hepatocellular carcinoma.
Hann HW; Lee J; Bussard A; Liu C; Jin YR; Guha K; Clayton MM; Ardlie K; Pellini MJ; Feitelson MA
Cancer Res; 2004 Oct; 64(20):7329-35. PubMed ID: 15492253
[TBL] [Abstract][Full Text] [Related]
36. Squamous cell carcinoma antigen-immunoglobulin M complexes as novel biomarkers for hepatocellular carcinoma.
Beneduce L; Castaldi F; Marino M; Quarta S; Ruvoletto M; Benvegnù L; Calabrese F; Gatta A; Pontisso P; Fassina G
Cancer; 2005 Jun; 103(12):2558-65. PubMed ID: 15887222
[TBL] [Abstract][Full Text] [Related]
37. Serum des-gamma-carboxyprothrombin level by a modified enzyme immunoassay method in hepatocellular carcinoma: clinical significance in small hepatocellular carcinoma.
Soga K; Watanabe T; Aikawa K; Toshima M; Shibasaki K; Aoyagi Y
Hepatogastroenterology; 1998; 45(23):1737-41. PubMed ID: 9840138
[TBL] [Abstract][Full Text] [Related]
38. Identification of cystatin B as a potential serum marker in hepatocellular carcinoma.
Lee MJ; Yu GR; Park SH; Cho BH; Ahn JS; Park HJ; Song EY; Kim DG
Clin Cancer Res; 2008 Feb; 14(4):1080-9. PubMed ID: 18281540
[TBL] [Abstract][Full Text] [Related]
39. Glutamine synthetase as an early marker for hepatocellular carcinoma based on proteomic analysis of resected small hepatocellular carcinomas.
Long J; Lang ZW; Wang HG; Wang TL; Wang BE; Liu SQ
Hepatobiliary Pancreat Dis Int; 2010 Jun; 9(3):296-305. PubMed ID: 20525558
[TBL] [Abstract][Full Text] [Related]
40. Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma.
Li LM; Hu ZB; Zhou ZX; Chen X; Liu FY; Zhang JF; Shen HB; Zhang CY; Zen K
Cancer Res; 2010 Dec; 70(23):9798-807. PubMed ID: 21098710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]